<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31935831</PMID><DateCompleted><Year>2021</Year><Month>02</Month><Day>05</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Jan</Month><Day>06</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Recombination Events and Conserved Nature of Receptor Binding Motifs in Coxsackievirus A9 Isolates.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">68</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v12010068</ELocationID><Abstract><AbstractText>Coxsackievirus A9 (CVA9) is an enterically transmitted enterovirus and one of the most pathogenic type among human enteroviruses. CVA9 isolates use a distinctive RGD (Arg-Gly-Asp) motif within VP1 capsid protein that defines its ability to bind to integrin receptor(s) for cellular entry. To investigate CVA9 evolution and pathogenicity, genetic relationships and recombination events were analyzed between 54 novel clinical isolates of CVA9, as well as 21 previously published full length CVA9 sequences from GenBank. Samples were investigated by partial sequencing of the novel VP1 and 3Dpol genes, as well as including the corresponding areas from GenBank sequences. Phylogenetic analyses were combined with clinical data in a further attempt to analyze whether sequence evolution reflects CVA9 pathogenicity in the phylogenies. Furthermore, VP1 gene was also analyzed for receptor binding sites including the RGD motif and the putative heparan sulfate (HS) site. Analysis of the 559-nucleotide-long VP1 sequences identified six clades. Although most of the strains within each clade showed geographical clustering, the grouping pattern of the isolates in the analysis of the VP1 gene was strikingly different from grouping of 3Dpol, which suggests that recombination events may have occurred in the region encoding the nonstructural proteins. Inclusion of clinical data did not provide any evidence of symptom based phylogenetic clustering of CVA9 isolates. Amino acid sequence analysis of the VP1 polypeptide demonstrated that the RGD motif was fully conserved among the isolates while the putative HS binding site was only found in one isolate. These data suggest that integrin binding is essential for virus tropism, but do not explain the symptom repertoire.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hietanen</LastName><ForeName>Eero</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-8548-3990</Identifier><AffiliationInfo><Affiliation>Institute of Biomedicine, University of Turku, 20520 Turku, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Susi</LastName><ForeName>Petri</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-9245-3271</Identifier><AffiliationInfo><Affiliation>Institute of Biomedicine, University of Turku, 20520 Turku, Finland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>01</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D036022">Capsid Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009842">Oligopeptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011991">Receptors, Virus</NameOfSubstance></Chemical><Chemical><RegistryNumber>78VO7F77PN</RegistryNumber><NameOfSubstance UI="C047981">arginyl-glycyl-aspartic acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>9050-30-0</RegistryNumber><NameOfSubstance UI="D006497">Heparitin Sulfate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.7.6</RegistryNumber><NameOfSubstance UI="D012321">DNA-Directed RNA Polymerases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D020816" MajorTopicYN="N">Amino Acid Motifs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D036022" MajorTopicYN="N">Capsid Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017124" MajorTopicYN="N">Conserved Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="N">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012321" MajorTopicYN="N">DNA-Directed RNA Polymerases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019143" MajorTopicYN="N">Evolution, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006497" MajorTopicYN="N">Heparitin Sulfate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009842" MajorTopicYN="N">Oligopeptides</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010802" MajorTopicYN="N">Phylogeny</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011991" MajorTopicYN="N">Receptors, Virus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011995" MajorTopicYN="N">Recombination, Genetic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Picornaviridae</Keyword><Keyword MajorTopicYN="N">coxsackievirus A9</Keyword><Keyword MajorTopicYN="N">phylogeny</Keyword><Keyword MajorTopicYN="N">receptor</Keyword><Keyword MajorTopicYN="N">recombination</Keyword><Keyword MajorTopicYN="N">viral evolution</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>9</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>12</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31935831</ArticleId><ArticleId IdType="pmc">PMC7019539</ArticleId><ArticleId IdType="doi">10.3390/v12010068</ArticleId><ArticleId IdType="pii">v12010068</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Oberste M.S., Maher K., Kilpatrick D.R., Pallansch M.A. Molecular evolution of the human enteroviruses: Correlation of serotype with VP1 sequence and application to picornavirus classification. J. Virol. 1999;73:1941&#x2013;1948. doi: 10.1128/JVI.73.3.1941-1948.1999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.73.3.1941-1948.1999</ArticleId><ArticleId IdType="pmc">PMC104435</ArticleId><ArticleId IdType="pubmed">9971773</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberste M.S., Nix W.A., Maher K., Pallansch M.A. Improved molecular identification of enteroviruses by RT-PCR and amplicon sequencing. J. Clin. Virol. 2003;26:375&#x2013;377. doi: 10.1016/S1386-6532(03)00004-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1386-6532(03)00004-0</ArticleId><ArticleId IdType="pubmed">12637088</ArticleId></ArticleIdList></Reference><Reference><Citation>Palacios G., Oberste M. Enteroviruses as agents of emerging infectious diseases. J. Neurovirol. 2005;11:424&#x2013;433. doi: 10.1080/13550280591002531.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13550280591002531</ArticleId><ArticleId IdType="pubmed">16287683</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuthill T.J., Groppelli E., Hogle J.M., Rowlands D.J. Picornaviruses. In: Johnson J., editor. Cell Entry by Non-Enveloped Viruses. Current Topics in Microbiology and Immunology, vol 343. Springer; Berlin/Heidelberg, Germany: 2010. pp. 43&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3018333</ArticleId><ArticleId IdType="pubmed">20397067</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang K.H., Auvinen P., Hyypia T., Stanway G. The nucleotide sequence of Coxsackievirus A9; Implications for receptor binding and enterovirus classification. J. Gen. Virol. 1989;70:3269&#x2013;3280. doi: 10.1099/0022-1317-70-12-3269.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-70-12-3269</ArticleId><ArticleId IdType="pubmed">2558158</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulli T., Koskimies P., Hyypi&#xe4; T. Molecular Comparison of Coxsackie A Virus Serotypes. Virology. 1995;212:30&#x2013;38. doi: 10.1006/viro.1995.1450.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.1995.1450</ArticleId><ArticleId IdType="pubmed">7676647</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomqvist S., Paananen A., Savolainen-Kopra C., Hovi T., Roivainen M. Eight Years of Experience with Molecular Identification of Human Enteroviruses. J. Clin. Microbiol. 2008;46:2410&#x2013;2413. doi: 10.1128/JCM.00313-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00313-08</ArticleId><ArticleId IdType="pmc">PMC2446933</ArticleId><ArticleId IdType="pubmed">18463218</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui A., Yu D., Zhu Z., Meng L., Li H., Liu J., Liu G., Mao N., Xu W. An outbreak of aseptic meningitis caused by coxsackievirus A9 in Gansu, the People&#x2019;s Republic of China. Virol. J. 2010;7:72. doi: 10.1186/1743-422X-7-72.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-7-72</ArticleId><ArticleId IdType="pmc">PMC2907575</ArticleId><ArticleId IdType="pubmed">20367886</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoki Y., Abe A., Ikeda T., Abiko C., Mizuta K., Yamaguchi I., Ahiko T. An Outbreak of Exanthematous Disease due to Coxsackievirus A9 in a Nursery in Yamagata, Japan, from February to March 2012. Jpn. J. Infect. Dis. 2012;65:367&#x2013;369. doi: 10.7883/yoken.65.367.</Citation><ArticleIdList><ArticleId IdType="doi">10.7883/yoken.65.367</ArticleId><ArticleId IdType="pubmed">22814168</ArticleId></ArticleIdList></Reference><Reference><Citation>Merilahti P., Koskinen S., Heikkil&#xe4; O., Karelehto E., Susi P. Endocytosis of integrin-binding human picornaviruses. Adv. Virol. 2012;2012 doi: 10.1155/2012/547530.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/547530</ArticleId><ArticleId IdType="pmc">PMC3514805</ArticleId><ArticleId IdType="pubmed">23227048</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendry E., Hatanaka H., Fry E., Smyth M., Tate J., Stanway G., Santti J., Maaronen M., Hyypi&#xe4; T., Stuart D. The crystal structure of coxsackievirus A9: New insights into the uncoating mechanisms of enteroviruses. Structure. 1999;7:1527&#x2013;1538. doi: 10.1016/S0969-2126(00)88343-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0969-2126(00)88343-4</ArticleId><ArticleId IdType="pubmed">10647183</ArticleId></ArticleIdList></Reference><Reference><Citation>Shakeel S., Seitsonen J.J.T., Kajander T., Laurinmaki P., Hyypia T., Susi P., Butcher S.J. Structural and Functional Analysis of Coxsackievirus A9 Integrin v 6 Binding and Uncoating. J. Virol. 2013;87:3943&#x2013;3951. doi: 10.1128/JVI.02989-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02989-12</ArticleId><ArticleId IdType="pmc">PMC3624221</ArticleId><ArticleId IdType="pubmed">23365426</ArticleId></ArticleIdList></Reference><Reference><Citation>Heikkil&#xe4; O., Susi P., Stanway G., Hyypi&#xe4; T. Integrin &#x3b1;V&#x3b2;6 is a high-affinity receptor for coxsackievirus A9. J. Gen. Virol. 2009;90:197&#x2013;204. doi: 10.1099/vir.0.004838-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.004838-0</ArticleId><ArticleId IdType="pubmed">19088289</ArticleId></ArticleIdList></Reference><Reference><Citation>Heikkil&#xe4; O., Susi P., Tevaluoto T., H&#xe4;rm&#xe4; H., Marjom&#xe4;ki V., Hyypi&#xe4; T., Kiljunen S. Internalization of coxsackievirus A9 is mediated by &#x3b2;2-microglobulin, dynamin, and Arf6 but not by caveolin-1 or clathrin. J. Virol. 2010;84:3666&#x2013;3681. doi: 10.1128/JVI.01340-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01340-09</ArticleId><ArticleId IdType="pmc">PMC2838097</ArticleId><ArticleId IdType="pubmed">20089652</ArticleId></ArticleIdList></Reference><Reference><Citation>Roivainen M., Hyypi&#xe4; T., Piirainen L., Kalkkinen N., Stanway G., Hovi T. RGD-dependent entry of coxsackievirus A9 into host cells and its bypass after cleavage of VP1 protein by intestinal proteases. J. Virol. 1991;65:4735&#x2013;4740.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC248930</ArticleId><ArticleId IdType="pubmed">1870199</ArticleId></ArticleIdList></Reference><Reference><Citation>Roivainen M., Piirainen L., Hovi T., Virtanen I., Riikonen T., Heino J., Hyypi&#xe4; T. Entry of coxsackievirus A9 into host cells: Specific interactions with &#x3b1;V&#x3b2;3 integrin, the vitronectin receptor. Virology. 1994;203:357&#x2013;365. doi: 10.1006/viro.1994.1494.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.1994.1494</ArticleId><ArticleId IdType="pubmed">7519807</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes P.J., Horsnell C., Hyypi&#xe4; T., Stanway G. The coxsackievirus A9 RGD motif is not essential for virus viability. J. Virol. 1995;69:8035&#x2013;8040.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC189749</ArticleId><ArticleId IdType="pubmed">7494317</ArticleId></ArticleIdList></Reference><Reference><Citation>Heikkil&#xe4; O., Merilahti P., Hakanen M., Karelehto E., Alanko J., Sukki M., Kiljunen S., Susi P. Integrins are not essential for entry of coxsackievirus A9 into SW480 human colon adenocarcinoma cells. Virol. J. 2016;13:171. doi: 10.1186/s12985-016-0619-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-016-0619-y</ArticleId><ArticleId IdType="pmc">PMC5069866</ArticleId><ArticleId IdType="pubmed">27756316</ArticleId></ArticleIdList></Reference><Reference><Citation>Triantafilou K., Fradelizi D., Wilson K., Triantafilou M. GRP78, a Coreceptor for Coxsackievirus A9, Interacts with Major Histocompatibility Complex Class I Molecules Which Mediate Virus Internalization. J. Virol. 2002;76:633&#x2013;643. doi: 10.1128/JVI.76.2.633-643.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.76.2.633-643.2002</ArticleId><ArticleId IdType="pmc">PMC136810</ArticleId><ArticleId IdType="pubmed">11752154</ArticleId></ArticleIdList></Reference><Reference><Citation>McLeish N.J., Williams C.H., Kaloudas D., Roivainen M.M., Stanway G. Symmetry-related clustering of positive charges is a common mechanism for heparan sulfate binding in enteroviruses. J. Virol. 2012;86:11163&#x2013;11170. doi: 10.1128/JVI.00640-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00640-12</ArticleId><ArticleId IdType="pmc">PMC3457184</ArticleId><ArticleId IdType="pubmed">22855495</ArticleId></ArticleIdList></Reference><Reference><Citation>Merilahti P., Karelehto E., Susi P. Role of Heparan Sulfate in Cellular Infection of Integrin-Binding Coxsackievirus A9 and Human Parechovirus 1 Isolates. PLoS ONE. 2016;11 doi: 10.1371/journal.pone.0147168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0147168</ArticleId><ArticleId IdType="pmc">PMC4718452</ArticleId><ArticleId IdType="pubmed">26785353</ArticleId></ArticleIdList></Reference><Reference><Citation>Santti J., Harvala H., Kinnunen L., Hyypi&#xe4; T. Molecular epidemiology and evolution of coxsackievirus A9. J. Gen. Virol. 2000;81:1361&#x2013;1372. doi: 10.1099/0022-1317-81-5-1361.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-81-5-1361</ArticleId><ArticleId IdType="pubmed">10769080</ArticleId></ArticleIdList></Reference><Reference><Citation>Drake J.W. Rates of spontaneous mutation among RNA viruses. Proc. Natl. Acad. Sci. USA. 1993;90:4171&#x2013;4175. doi: 10.1073/pnas.90.9.4171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.90.9.4171</ArticleId><ArticleId IdType="pmc">PMC46468</ArticleId><ArticleId IdType="pubmed">8387212</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoll J., Galama J., Melchers W. Intratypic genome variability of the coxsackievirus B1 2A protease region. J. Gen. Virol. 1994;75:687&#x2013;692. doi: 10.1099/0022-1317-75-3-687.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-75-3-687</ArticleId><ArticleId IdType="pubmed">8126468</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes M.S., Hoey E.M., Coyle P.V. A nucleotide sequence comparison of coxsackievirus B4 isolates from aquatic samples and clinical specimens. Epidemiol. Infect. 1993;110:389&#x2013;398. doi: 10.1017/S0950268800068333.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268800068333</ArticleId><ArticleId IdType="pmc">PMC2272253</ArticleId><ArticleId IdType="pubmed">8386098</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopecka H., Brown B., Pallansch M. Genotypic variation in Coxsackievirus B5 isolates from three different outbreaks in the United States. Virus Res. 1995;38:125&#x2013;136. doi: 10.1016/0168-1702(95)00055-U.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0168-1702(95)00055-U</ArticleId><ArticleId IdType="pubmed">8578854</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown B.A., Oberste M.S., Alexander J.P., Kennett M.L., Pallansch M.A. Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J. Virol. 1999;73:9969&#x2013;9975. doi: 10.1128/JVI.73.12.9969-9975.1999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.73.12.9969-9975.1999</ArticleId><ArticleId IdType="pmc">PMC113047</ArticleId><ArticleId IdType="pubmed">10559310</ArticleId></ArticleIdList></Reference><Reference><Citation>Gj&#xf8;en K., Bruu A.-L., &#xd8;rstavik I. Intratypic genome variability of echovirus type 30 in part of the VP4/VP2 coding region. Arch. Virol. 1996;141:901&#x2013;908. doi: 10.1007/BF01718164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01718164</ArticleId><ArticleId IdType="pubmed">8678835</ArticleId></ArticleIdList></Reference><Reference><Citation>Santti J., Hyypi&#xe4; T., Kinnunen L., Salminen M. Evidence of recombination among enteroviruses. J. Virol. 1999;73:8741&#x2013;8749. doi: 10.1128/JVI.73.10.8741-8749.1999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.73.10.8741-8749.1999</ArticleId><ArticleId IdType="pmc">PMC112895</ArticleId><ArticleId IdType="pubmed">10482628</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez N., Triantafilou K., Stanway G., Wilson K.M., Triantafilou M., Takada Y. Involvement of &#x3b2;2-microglobulin and integrin &#x3b1;v&#x3b2;3 molecules in the coxsackievirus A9 infectious cycle. J. Gen. Virol. 1999;80:2591&#x2013;2600.</Citation><ArticleIdList><ArticleId IdType="pubmed">10573151</ArticleId></ArticleIdList></Reference><Reference><Citation>Triantafilou M., Triantafilou K., Wilson K.M., Takada Y., Fernandez N. High affinity interactions of Coxsackievirus A9 with integrin &#x3b1;v&#x3b2;3 (CD51/61) require the CYDMKTTC sequence of &#x3b2;3, but do not require the RGD sequence of the CAV-9 VP1 protein. Hum. Immunol. 2000;61:453&#x2013;459. doi: 10.1016/S0198-8859(00)00103-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0198-8859(00)00103-8</ArticleId><ArticleId IdType="pubmed">10773347</ArticleId></ArticleIdList></Reference><Reference><Citation>Triantafilou M., Wilson K.M., Triantafilou K. Identification of echovirus 1 and coxsackievirus A9 receptor molecules via a novel flow cytometric quantification method. Cytometry. 2001;43:279&#x2013;289. doi: 10.1002/1097-0320(20010401)43:4&lt;279::AID-CYTO1060&gt;3.0.CO;2-B.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1097-0320(20010401)43:4&lt;279::AID-CYTO1060&gt;3.0.CO;2-B</ArticleId><ArticleId IdType="pubmed">11260595</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvala H. Pathogenesis of coxsackievirus A9 in mice: Role of the viral arginine-glycine-aspartic acid motif. J. Gen. Virol. 2003;84:2375&#x2013;2379. doi: 10.1099/vir.0.19246-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.19246-0</ArticleId><ArticleId IdType="pubmed">12917458</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvala H. Tissue tropism of recombinant coxsackieviruses in an adult mouse model. J. Gen. Virol. 2005;86:1897&#x2013;1907. doi: 10.1099/vir.0.80603-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.80603-0</ArticleId><ArticleId IdType="pubmed">15958668</ArticleId></ArticleIdList></Reference><Reference><Citation>Leitch E.C.M., Harvala H., Robertson I., Ubillos I., Templeton K., Simmonds P. Erratum to &#x201c;Direct identification of human enterovirus serotypes in cerebrospinal fluid by amplification and sequencing of the VP1 region&#x201d; [J. Clin. Virol. 44 (2009) 119&#x2013;124] J. Clin. Virol. 2011;51:286. doi: 10.1016/j.jcv.2011.05.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2011.05.010</ArticleId><ArticleId IdType="pubmed">19135410</ArticleId></ArticleIdList></Reference><Reference><Citation>Gouy M., Guindon S., Gascuel O. SeaView Version 4: A Multiplatform Graphical User Interface for Sequence Alignment and Phylogenetic Tree Building. Mol. Biol. Evol. 2010;27:221&#x2013;224. doi: 10.1093/molbev/msp259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msp259</ArticleId><ArticleId IdType="pubmed">19854763</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura M. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J. Mol. Evol. 1980;16:111&#x2013;120. doi: 10.1007/BF01731581.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01731581</ArticleId><ArticleId IdType="pubmed">7463489</ArticleId></ArticleIdList></Reference><Reference><Citation>Drummond A.J., Suchard M.A., Xie D., Rambaut A. Bayesian phylogenetics with BEAUti and the BEAST 1.7. Mol. Biol. Evol. 2012;29:1969&#x2013;1973. doi: 10.1093/molbev/mss075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/mss075</ArticleId><ArticleId IdType="pmc">PMC3408070</ArticleId><ArticleId IdType="pubmed">22367748</ArticleId></ArticleIdList></Reference><Reference><Citation>Shapiro B., Rambaut A., Pybus O.G., Holmes E.C. A phylogenetic method for detecting positive epistasis in gene sequences and its application to RNA virus evolution. Mol. Biol. Evol. 2006;23:1724&#x2013;1730. doi: 10.1093/molbev/msl037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msl037</ArticleId><ArticleId IdType="pubmed">16774976</ArticleId></ArticleIdList></Reference><Reference><Citation>Okonechnikov K., Golosova O., Fursov M., Varlamov A., Vaskin Y., Efremov I., German Grehov O.G., Kandrov D., Rasputin K., Syabro M., et al. Unipro UGENE: A unified bioinformatics toolkit. Bioinformatics. 2012;28:1166&#x2013;1167. doi: 10.1093/bioinformatics/bts091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bts091</ArticleId><ArticleId IdType="pubmed">22368248</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall T.A. BioEdit: A user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp. Ser. 1999;41:95&#x2013;98.</Citation></Reference><Reference><Citation>Williams C.H., Kajander T., Hyypia T., Jackson T., Sheppard D., Stanway G. Integrin v 6 is an RGD-Dependent Receptor for Coxsackievirus A9. J. Virol. 2004;78:6967&#x2013;6973. doi: 10.1128/JVI.78.13.6967-6973.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.13.6967-6973.2004</ArticleId><ArticleId IdType="pmc">PMC421648</ArticleId><ArticleId IdType="pubmed">15194773</ArticleId></ArticleIdList></Reference><Reference><Citation>Pybus O.G., Tatem A.J., Lemey P. Virus evolution and transmission in an ever more connected world. Proc. R. Soc. B Biol. Sci. 2015;282 doi: 10.1098/rspb.2014.2878.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rspb.2014.2878</ArticleId><ArticleId IdType="pmc">PMC4707738</ArticleId><ArticleId IdType="pubmed">26702033</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson T., Blakemore W., Newman J.W.I., Knowles N.J., Mould A.P., Humphries M.J., King A.M.Q. Foot-and-mouth disease virus is a ligand for the high-affinity binding conformation of integrin &#x3b1;V&#x3b2;1: Influence of the leucine residue within the RGDL motif on selectivity of integrin binding. J. Gen. Virol. 2000;81:1383&#x2013;1391. doi: 10.1099/0022-1317-81-5-1383.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-81-5-1383</ArticleId><ArticleId IdType="pubmed">10769082</ArticleId></ArticleIdList></Reference><Reference><Citation>DiCara D., Burman A., Clark S., Berryman S., Howard M.J., Hart I.R., Marshall J.F., Jackson T. Foot-and-mouth disease virus forms a highly stable, EDTA-resistant complex with its principal receptor, integrin &#x3b1;V&#x3b2;6: Implications for infectiousness. J. Virol. 2008;82:1537&#x2013;1546. doi: 10.1128/JVI.01480-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01480-07</ArticleId><ArticleId IdType="pmc">PMC2224447</ArticleId><ArticleId IdType="pubmed">18045932</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardin A.D., Weintraub H.J. Molecular modeling of protein-glycosaminoglycan interactions. Arteriosclerosis. 1989;9:21&#x2013;32. doi: 10.1161/01.ATV.9.1.21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.ATV.9.1.21</ArticleId><ArticleId IdType="pubmed">2463827</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>